Received for p)ublication Juiie 4, 1964 PREVIOUTS studies (Marks and Bishop, 1957 Benjamin, 1960 anid Boyd, (lapp and Finnegan, 1962) have shown that there is a decrease in glucose toleranice in a variety of malignant diseases. In one study (Boyd et al., 1962) glucose tolerance was improved after oestrogens had been given for breast or prostatic carcinoma, and this was accompanied by clinical evidence of regression of the malignant disease. It was acknowledged that this phenomenon might be due merely to the effects of oestrogens and be unrelated to the regression of tumour.
This paper is concerned with ain attempt to show a relationship between abnormal glucose tolerance in cancer of various types and methods of treatment other than the administration of oestrogens.
M1ATERIAL AND METHODS
In all of the patients studied the diagnosis of caincer had been confirmed histologically. Twenty-nine patients were tested. Nine patients received Ino specific treatment because the tumour was inoperable or because, in the circumstances, other forms of treatment were considered inappropriate. A further seven patients were treated, but for a variety of reasons a second test could not be carried out (some of the patients died soon after surgical operation, and others were not well eniough to make the journey to the hospital out-patient department).
The thirteen remaining patients were tested at intervals varying from one to three months after the first test and at a time when they were considered to have improved clinically as a result of treatment. Details of diagnosis and treatment in the individual cases are giveii in Table I. All patients were taking a normal diet but oni the day of the test were fasting and at rest. None of them had clinical evidence of endocrine, renal or hepatic disease. The test was performed in the manner previously described (Boyd et al., 1962) and the result expressed as the glucose iincrement index (I.I.) as suggested by Amatuzio et al. (1953) . Blood glucose levels were again determined by enzymatic methods as " true glucose " (Keilin and Hartree, 1945) .
RESULTS
The findings are summarised in Table I by Boyd et al. (1962) , that the improvement seen in patients with prostatic and mammary carcinoma is due merely to oestrogen effect and not to any associated changes in the malignant disease.
This study may also help to underline the fact that abnormal glucose tolerance is not a constant feature of malignant disease, that it cannot be related to the success or failure of treatment, and that tests to detect it are unreliable as diagnostic measures for malignant disease.
SUMMARY
The results are presented of intravenous glucose tolerance tests performed on 13 patients with a variety of malignant diseases before and after several forms of treatment. The difference is not statistically significant; and this suggests that in malignant disease, treatment has no effect on glucose tolerance.
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